Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 411-370-1 | CAS number: 82857-68-9 GM 102 E
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From June 1994 to July 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP- and OECD TG-compliant study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Report date:
- 1994
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- GM102E
- IUPAC Name:
- GM102E
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Physical state: white powder
- Lot/batch No.: 8724
- Expiration date of the lot/batch: November 1994
- Storage condition of test material: no specific requirements
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS: Sprague Dawley Crl: CD (SD) BR rats
- Source: Charles River Italia S.p.A.
- Age at study initiation: 7/9 weeks
- Weight at study initiation: Males: 225 - 250 g ; Females: 200 - 225 g
- Fasting period before study: 16 hours
- Housing: 5 animals/sex/cage in T11C air-conditioned room, grill cage 40.5x38.5x18 cm with stainless feeder
- Diet (e.g. ad libitum): ad libitum, GLP 4RF1 Charles River Italia's feed licensee Mucedola s.r.l., Settimo Milanese
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2 °C
- Humidity (%): 55 +/- 10
- Air changes (per hr): 20/hours filtered on HEPA 99.97%
- Photoperiod (hrs dark / hrs light): 12 hour cycles (light: 7am - 7 pm)
IN-LIFE DATES: From: june 15, 1994 To: july 1, 1994
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Deionized water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 6.7, 10, 15 mg/ml
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg - Doses:
- 67 mg/kg, 100 mg/kg, 150 mg/kg
- No. of animals per sex per dose:
- 67 mg/kg : 5 Males and 5 females
100 mg/kg: 5 males
150 mg/kg: 5 males - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 30 min, 2, 4 ,6 hours post-dosing, then twice a day
- Necropsy of survivors performed: yes
- Other examinations performed:
clinical signs: daily
body weight: day 1, 3, 8 and 14
organ weights, histopathology, other: No - Statistics:
- Method of Probit (Bliss-Finney) - AP. Rosiello et al., J. Tox. and Env. Health, 3:797-809, 1977
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 123 mg/kg bw
- 95% CL:
- 100.4 - 150.2
- Remarks on result:
- other: Slope of the mortality curve: 4.33
- Mortality:
- Male: 67 mg/kg bw; Number of animals: 5; Number of deaths: 0
Male: 100 mg/kg bw; Number of animals: 5; Number of deaths: 1
Male: 150 mg/kg bw; Number of animals: 5; Number of deaths: 4
Female: 67 mg/kg bw; Number of animals: 5; Number of deaths: 0 - Clinical signs:
- other: Signs of toxicity related to dose levels: Piloerection, hunched posture and diarrhea were observed in animals treated at 67 mg/Kg starting from 2 hours and lasting up to 24 hours after the administration. Animals treated at 100 and 150 mg/Kg showed th
- Gross pathology:
- Effects on organs: Animals which died showed congestion of the lungs, kidneys, stomach, intestine and thymus and also paleness of the liver and thinning walls with catharral or catharral-hemorrhagic content in the intestine. At the autopsy carried out at the end of the observation period no appreciable macroscopic findings were evident in any treated rat.
Applicant's summary and conclusion
- Interpretation of results:
- toxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In conclusion, the LD50 to rats was found to be 123 mg/kg.
From this value the substance is to be classified as toxic if swallowed according to the CLP Regulation (EC) No. 1272/2008. - Executive summary:
The acute oral toxicity of the test item GM102E was investigated in a study performed on Sprague Dawley rats at concentrations of 67, 100 and 150 mg/kg.
The test was performed according to OECD guideline 401 and in compliance with GLP.
The test item was administered by gavage to 5 male rats per dose and a further group of 5 females was tested at 67 mg/kg of GM102E. The test item was dissolved in deionized water before administration and the administration volume was kept constant at 10 ml/kg b.w. in all the groups.
All rats were treated after a 16 hours fasting period. The animals were weighed twice before treatment (at randomization and on day 1 just before the study) and on days 3, 8 and 14 after exposure period. They were clinically observed for 14 days following treatment. On day 15 all treated rats were killed by excision of the femoral arteries, after i.p. overdosage anesthesia with 5% sodium pentobarbital. Animals which died and animals killed at the end of the study were submitted to a thourough autopsy.
Piloerection, hunched posture and diarrhea were clinically observed in animals treated at the lowest dose (67 mg/kg) starting from 2 hours and lasting up to 24 hours after the test item administration. Animals treated at the highest doses (100 and 150 mg/kg) showed the same clinical signs and, in addition, sedation and/or hypoactivity and sporadic cases of shallow breathing, chromodacryorrhea and pallor of the skin and apparent mucosae. These signs started from 30 minutes – 4 hours and lasted up to 6 hours – day 3 of the study. Recovery of all surviving rats was achieved within days 2 – 4 of the study.
Body weight gain resulted unaffected by treatment in animals treated at the lowest dose. Surviving male rats treated at 100 and 150 mg/kg showed decrease in body weight or low body weight gain at the day 3 weighing. Body weight gain returned to normal at the subsequent recordings.
At the autopsy, animals which died showed congestion of the lungs, kidnays, stomach, intestine and thymus and also paleness of the liver and thinning walls with catharral or catharral-hemorrhagic content in the intestine.
At the autopsy carried out at the end of the observation period no appreciable macroscopic findings were evident in any treated rat.
One male treated at 100 mg/kg and 4 males treated at 150 mg/kg died within 2 hours of treatment. No animals treated at 67 mg/kg died. The LD50 was calculated to be 122.8 mg/kg with 95% confidence limits of 100.4 – 150.2 mg/kg.
Based on these results and according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (CLP), GM102E should be classified as toxic by ingestion (Acute tox. Category 3, H301).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.